$CRTO
Criteo S.A. Stock $crto

$crto Overview Financials Valuation SEC Filings Company Website

2021 Q1 Form 10-Q Financial Statement

#000157642721000042 Filed on May 05, 2021

Income Statement

Concept	2021 Q1	2020 Q1
Revenue	$541.1M	$503.4M
YoY Change	7.49%	-9.81%
Cost Of Revenue	$327.7M	$297.4M
YoY Change	10.19%	-7.77%
Gross Profit	$178.7M	$172.2M
YoY Change	3.77%	-17.86%
Gross Profit Margin	33.03%	34.21%
Selling, General & Admin	$112.8M	$110.9M
YoY Change	1.71%	-14.49%
% of Gross Profit	63.11%	64.39%
Research & Development	$31.70M	$37.52M
YoY Change	-15.51%	-19.46%
% of Gross Profit	17.74%	21.78%
Depreciation & Amortization	$17.23M	$27.04M
YoY Change	-36.31%	37.67%
% of Gross Profit	9.64%	15.7%
Operating Expenses	$144.5M	$148.4M
YoY Change	-2.64%	-15.8%
Operating Profit	$34.22M	$23.80M
YoY Change	43.77%	-28.72%
Interest Expense	$540.0K	$432.0K
YoY Change	25.0%	-17.4%
% of Operating Profit	1.58%	1.81%
Other Income/Expense, Net	-$700.0K	-$334.0K
YoY Change	109.58%	-83.3%
Pretax Income	$33.50M	$23.47M
YoY Change	42.75%	-25.31%
Income Tax	$10.05M	$7.040M
% Of Pretax Income	30.0%	30.0%
Net Earnings	$22.41M	$15.46M
YoY Change	44.94%	-19.15%
Net Earnings / Revenue	4.14%	3.07%
Basic Earnings Per Share	$0.37	$0.25
Diluted Earnings Per Share	$0.35	$0.25
COMMON SHARES
Basic Shares Outstanding	60.74M shares	61.69M shares
Diluted Shares Outstanding	64.08M shares	62.13M shares

Balance Sheet

Concept	2021 Q1	2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$537.6M	$436.5M
YoY Change	23.17%	10.29%
Cash & Equivalents	$520.1M	$436.5M
Short-Term Investments	$17.59M
Other Short-Term Assets	$22.49M	$19.83M
YoY Change	13.42%	-19.83%
Inventory
Prepaid Expenses	$14.41M	$11.24M
Receivables	$416.9M	$364.4M
Other Receivables	$86.17M	$92.22M
Total Short-Term Assets	$1.059B	$909.2M
YoY Change	16.53%	4.23%
LONG-TERM ASSETS
Property, Plant & Equipment	$168.0M	$181.8M
YoY Change	-7.6%	0.82%
Goodwill	$322.8M	$315.3M
YoY Change	2.4%	-0.57%
Intangibles	$79.44M	$79.82M
YoY Change	-0.47%	-25.56%
Long-Term Investments	$43.07M	$20.37M
YoY Change	111.4%	0.21%
Other Assets	$13.51M	$29.46M
YoY Change	-54.13%	-39.05%
Total Long-Term Assets	$723.1M	$766.7M
YoY Change	-5.68%	-12.24%
TOTAL ASSETS
Total Short-Term Assets	$1.059B	$909.2M
Total Long-Term Assets	$723.1M	$766.7M
Total Assets	$1.783B	$1.676B
YoY Change	6.37%	-4.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$349.6M	$304.1M
YoY Change	14.94%	-14.58%
Accrued Expenses	$116.0M	$120.5M
YoY Change	-3.81%	6.75%
Deferred Revenue	$988.0K	$186.0K
YoY Change	431.18%	-73.91%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$2.114M	$2.303M
YoY Change	-8.21%	44.03%
Total Short-Term Liabilities	$557.1M	$517.1M
YoY Change	7.75%	-8.47%
LONG-TERM LIABILITIES
Long-Term Debt	$371.0K	$555.0K
YoY Change	-33.15%	-75.69%
Other Long-Term Liabilities	$9.807M	$2.715M
YoY Change	261.22%	-42.31%
Total Long-Term Liabilities	$81.74M	$132.2M
YoY Change	-38.18%	-30.12%
TOTAL LIABILITIES
Total Short-Term Liabilities	$557.1M	$517.1M
Total Long-Term Liabilities	$81.74M	$132.2M
Total Liabilities	$638.9M	$649.3M
YoY Change	-1.6%	-13.9%
SHAREHOLDERS EQUITY
Retained Earnings	$510.5M	$450.5M
YoY Change	13.33%	11.73%
Common Stock	$704.2M	$678.7M
YoY Change	3.76%	5.51%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$87.26M	$79.83M
YoY Change	9.31%	104.29%
Treasury Stock Shares	5.598M shares	4.500M shares
Shareholders Equity	$1.110B	$995.0M
YoY Change
Total Liabilities & Shareholders Equity	$1.783B	$1.676B
YoY Change	6.37%	-4.01%

Cashflow Statement

Concept	2021 Q1	2020 Q1
OPERATING ACTIVITIES
Net Income	$22.41M	$15.46M
YoY Change	44.94%	-19.15%
Depreciation, Depletion And Amortization	$17.23M	$27.04M
YoY Change	-36.31%	37.67%
Cash From Operating Activities	$77.36M	$56.74M
YoY Change	36.34%	-15.59%
INVESTING ACTIVITIES
Capital Expenditures	-$13.78M	-$11.74M
YoY Change	17.41%	-50.44%
Acquisitions		$0.00
YoY Change		-100.0%
Other Investing Activities	-$3.252M	$889.0K
YoY Change	-465.8%	2863.33%
Cash From Investing Activities	-$17.03M	-$10.85M
YoY Change	57.01%	-62.65%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$2.856M	$18.24M
YoY Change	-84.34%	-165890.91%
Debt Paid & Issued, Net	$182.0K
YoY Change
Cash From Financing Activities	-$3.416M	-$18.76M
YoY Change	-81.79%	9722.51%
NET CHANGE
Cash From Operating Activities	$77.36M	$56.74M
Cash From Investing Activities	-$17.03M	-$10.85M
Cash From Financing Activities	-$3.416M	-$18.76M
Net Change In Cash	$32.05M	$17.74M
YoY Change	80.63%	-43.39%
FREE CASH FLOW
Cash From Operating Activities	$77.36M	$56.74M
Capital Expenditures	-$13.78M	-$11.74M
Free Cash Flow	$91.14M	$68.48M
YoY Change	33.09%	-24.67%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001576427
CY2021Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2021Q1	dei	Amendment Flag AmendmentFlag	false
CY2021Q1	dei	Document Type DocumentType	10-Q
CY2021Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2021Q1	dei	Entity File Number EntityFileNumber	001-36153
CY2021Q1	dei	Entity Registrant Name EntityRegistrantName	Criteo S.A.
CY2021Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	I0
CY2021Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	32 Rue Blanche
CY2021Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Paris
CY2021Q1	dei	Entity Address Country EntityAddressCountry	FR
CY2021Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	75009
CY2021Q1	dei	Country Region CountryRegion	33
CY2021Q1	dei	City Area Code CityAreaCode	40
CY2021Q1	dei	Local Phone Number LocalPhoneNumber	40 22 90
CY2021Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2021Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2021Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021Q1	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	60727589	shares
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	520060000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	488011000	USD
CY2021Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	38700000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	39900000	USD
CY2021Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	416910000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	474055000	USD
CY2021Q1	crto	Prepaid Income Taxes PrepaidIncomeTaxes	12750000	USD
CY2020Q4	crto	Prepaid Income Taxes PrepaidIncomeTaxes	11092000	USD
CY2021Q1	crto	Prepaid Other Taxesand Other Taxes Receivable PrepaidOtherTaxesandOtherTaxesReceivable	69692000	USD
CY2020Q4	crto	Prepaid Other Taxesand Other Taxes Receivable PrepaidOtherTaxesandOtherTaxesReceivable	69987000	USD
CY2021Q1	us-gaap	Other Assets Current OtherAssetsCurrent	22494000	USD
CY2020Q4	us-gaap	Other Assets Current OtherAssetsCurrent	21405000	USD
CY2021Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	17586000	USD
CY2020Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	0	USD
CY2021Q1	us-gaap	Assets Current AssetsCurrent	1059492000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	1064550000	USD
CY2021Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	168036000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	189505000	USD
CY2021Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	79440000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	79744000	USD
CY2021Q1	us-gaap	Goodwill Goodwill	322821000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	325805000	USD
CY2021Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	1201000	USD
CY2021Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	96266000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	114012000	USD
CY2021Q1	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	28281000	USD
CY2020Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	41809000	USD
CY2021Q1	us-gaap	Nontrade Receivables Noncurrent NontradeReceivablesNoncurrent	14788000	USD
CY2020Q4	us-gaap	Nontrade Receivables Noncurrent NontradeReceivablesNoncurrent	18109000	USD
CY2021Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	13511000	USD
CY2020Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	19876000	USD
CY2021Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	723143000	USD
CY2020Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	788860000	USD
CY2021Q1	us-gaap	Assets Assets	1782635000	USD
CY2020Q4	us-gaap	Assets Assets	1853410000	USD
CY2021Q1	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	347209000	USD
CY2020Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	367025000	USD
CY2021Q1	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	1773000	USD
CY2020Q4	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	2250000	USD
CY2020Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	2626000	USD
CY2021Q1	crto	Financial Liabilities Current FinancialLiabilitiesCurrent	2114000	USD
CY2020Q4	crto	Financial Liabilities Current FinancialLiabilitiesCurrent	2889000	USD
CY2021Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	44501000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	48388000	USD
CY2021Q1	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	56192000	USD
CY2020Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	58491000	USD
CY2021Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	71450000	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	85272000	USD
CY2021Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	32693000	USD
CY2020Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	33390000	USD
CY2021Q1	us-gaap	Liabilities Current LiabilitiesCurrent	557133000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	600331000	USD
CY2021Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	4066000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	5297000	USD
CY2021Q1	us-gaap	Defined Benefit Pension Plan Liabilities Noncurrent DefinedBenefitPensionPlanLiabilitiesNoncurrent	5621000	USD
CY2020Q4	us-gaap	Defined Benefit Pension Plan Liabilities Noncurrent DefinedBenefitPensionPlanLiabilitiesNoncurrent	6167000	USD
CY2021Q1	crto	Financial Liabilities Noncurrent FinancialLiabilitiesNoncurrent	371000	USD
CY2020Q4	crto	Financial Liabilities Noncurrent FinancialLiabilitiesNoncurrent	386000	USD
CY2021Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	61874000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	83007000	USD
CY2021Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	9807000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	5535000	USD
CY2021Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	81739000	USD
CY2020Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	100392000	USD
CY2021Q1	us-gaap	Liabilities Liabilities	638872000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	700723000	USD
CY2021Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.025
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.025
CY2021Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	66391906	shares
CY2021Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	66391906	shares
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	66391906	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	66272106	shares
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	66272106	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	66272106	shares
CY2021Q1	us-gaap	Common Stock Value CommonStockValue	2164000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	2161000	USD
CY2021Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	5597601	shares
CY2020Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	5632536	shares
CY2021Q1	us-gaap	Treasury Stock Value TreasuryStockValue	87263000	USD
CY2020Q4	us-gaap	Treasury Stock Value TreasuryStockValue	85570000	USD
CY2021Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	702022000	USD
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	693164000	USD
CY2021Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-17825000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	16028000	USD
CY2021Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	510528000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	491359000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	1109626000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	1117142000	USD
CY2021Q1	us-gaap	Minority Interest MinorityInterest	34137000	USD
CY2020Q4	us-gaap	Minority Interest MinorityInterest	35545000	USD
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1143763000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1152687000	USD
CY2021Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1782635000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1853410000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	541077000	USD
CY2020Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	503376000	USD
CY2021Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	327667000	USD
CY2020Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	297364000	USD
CY2021Q1	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	34712000	USD
CY2020Q1	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	33806000	USD
CY2021Q1	us-gaap	Gross Profit GrossProfit	178698000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	23468000	USD
CY2020Q1	us-gaap	Gross Profit GrossProfit	172206000	USD
CY2021Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	31697000	USD
CY2020Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	37515000	USD
CY2021Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	79354000	USD
CY2020Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	84974000	USD
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	33428000	USD
CY2020Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	25915000	USD
CY2021Q1	us-gaap	Operating Expenses OperatingExpenses	144479000	USD
CY2020Q1	us-gaap	Operating Expenses OperatingExpenses	148404000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	34219000	USD
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	23802000	USD
CY2021Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-718000	USD
CY2020Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-334000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	33501000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10051000	USD
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.37
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7040000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	23450000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	16428000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	22406000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	15459000	USD
CY2021Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1044000	USD
CY2020Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	969000	USD
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	60741674	shares
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	61691001	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	64077409	shares
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	62125582	shares
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.25
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.35
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.25
CY2021Q1	us-gaap	Profit Loss ProfitLoss	23450000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	39000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	16428000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-36983000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-15932000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-629000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-1734000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-36354000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-14198000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-12904000	USD
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	2230000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-11446000	USD
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1281000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-1458000	USD
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	949000	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1037988000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	16428000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-14198000	USD
CY2021Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	100000000.0	USD
CY2021Q1	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	149960	shares
CY2021Q1	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	32.9
CY2021Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	184895	shares
CY2020Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	18239000	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	8131000	USD
CY2020Q1	us-gaap	Stockholders Equity Other StockholdersEquityOther	3541000	USD
CY2020Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1026608000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1152687000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	23450000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-36354000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2151000	USD
CY2021Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	4930000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6760000	USD
CY2021Q1	us-gaap	Stockholders Equity Other StockholdersEquityOther	0	USD
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1143763000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	23450000	USD
CY2020Q1	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	-7487000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	16428000	USD
CY2021Q1	us-gaap	Adjustments Noncash Items To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	30017000	USD
CY2020Q1	us-gaap	Adjustments Noncash Items To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	32828000	USD
CY2021Q1	crto	Depreciation Depletionand Amortizationand Provisionsfor Various DepreciationDepletionandAmortizationandProvisionsforVarious	17225000	USD
CY2020Q1	crto	Depreciation Depletionand Amortizationand Provisionsfor Various DepreciationDepletionandAmortizationandProvisionsforVarious	27044000	USD
CY2021Q1	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-3945000	USD
CY2020Q1	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-2266000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	7215000	USD
CY2020Q1	us-gaap	Share Based Compensation ShareBasedCompensation	8502000	USD
CY2021Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	4998000	USD
CY2020Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2678000	USD
CY2021Q1	us-gaap	Increase Decrease In Income Taxes IncreaseDecreaseInIncomeTaxes	-3379000	USD
CY2020Q1	us-gaap	Increase Decrease In Income Taxes IncreaseDecreaseInIncomeTaxes	-2329000	USD
CY2021Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-13000	USD
CY2020Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-23000	USD
CY2021Q1	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	-23895000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-47226000	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-99388000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-10640000	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-81679000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	5050000	USD
CY2020Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	10398000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-4527000	USD
CY2020Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-945000	USD
CY2021Q1	crto	Increase Decrease In Operating Lease Liabilities Assets IncreaseDecreaseInOperatingLeaseLiabilitiesAssets	-3114000	USD
CY2020Q1	crto	Increase Decrease In Operating Lease Liabilities Assets IncreaseDecreaseInOperatingLeaseLiabilitiesAssets	1121000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	77362000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	56743000	USD
CY2021Q1	crto	Payments To Acquire Intangible Assets Property Plant And Equipment PaymentsToAcquireIntangibleAssetsPropertyPlantAndEquipment	11953000	USD
CY2020Q1	crto	Payments To Acquire Intangible Assets Property Plant And Equipment PaymentsToAcquireIntangibleAssetsPropertyPlantAndEquipment	11258000	USD
CY2021Q1	crto	Increase Decreasein Accounts Payable Relatedto Intangible Assets Property Plantand Equipment IncreaseDecreaseinAccountsPayableRelatedtoIntangibleAssetsPropertyPlantandEquipment	-1827000	USD
CY2020Q1	crto	Increase Decreasein Accounts Payable Relatedto Intangible Assets Property Plantand Equipment IncreaseDecreaseinAccountsPayableRelatedtoIntangibleAssetsPropertyPlantandEquipment	-479000	USD
CY2021Q1	crto	Paymentsfor Proceedsfrom Changein Other Financial Noncurrent Assets PaymentsforProceedsfromChangeinOtherFinancialNoncurrentAssets	3252000	USD
CY2020Q1	crto	Paymentsfor Proceedsfrom Changein Other Financial Noncurrent Assets PaymentsforProceedsfromChangeinOtherFinancialNoncurrentAssets	-889000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-17032000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-10848000	USD
CY2021Q1	us-gaap	Proceeds From Repayments Of Other Debt ProceedsFromRepaymentsOfOtherDebt	-182000	USD
CY2020Q1	us-gaap	Proceeds From Repayments Of Other Debt ProceedsFromRepaymentsOfOtherDebt	-170000	USD
CY2021Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2074000	USD
CY2020Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	4000	USD
CY2021Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	4930000	USD
CY2020Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	18241000	USD
CY2021Q1	crto	Proceeds From Payments For Change In Other Financial Liabilities ProceedsFromPaymentsForChangeInOtherFinancialLiabilities	-378000	USD
CY2020Q1	crto	Proceeds From Payments For Change In Other Financial Liabilities ProceedsFromPaymentsForChangeInOtherFinancialLiabilities	-354000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3416000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-18761000	USD
CY2021Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-24865000	USD
CY2020Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-9391000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	32049000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	17743000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	488011000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	418763000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	520060000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	436506000	USD
CY2021Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	8432000	USD
CY2020Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	12047000	USD
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	367000	USD
CY2020Q1	us-gaap	Interest Paid Net InterestPaidNet	349000	USD
CY2021Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6800000	USD
CY2020Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8100000	USD
CY2021Q1	us-gaap	Restructuring Charges RestructuringCharges	5200000	USD
CY2020Q4	us-gaap	Restructuring Reserve RestructuringReserve	510000	USD
CY2021Q1	us-gaap	Restructuring Charges RestructuringCharges	5152000	USD
CY2021Q1	us-gaap	Payments For Restructuring PaymentsForRestructuring	84000	USD
CY2021Q1	us-gaap	Restructuring Reserve RestructuringReserve	5578000	USD
CY2021Q1	us-gaap	Concentration Risk Credit Risk Financial Instrument Maximum Exposure ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure	569751000	USD
CY2020	us-gaap	Concentration Risk Credit Risk Financial Instrument Maximum Exposure ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure	625365000	USD
CY2021Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	154885000	USD
CY2020Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	162457000	USD
CY2021Q1	us-gaap	Cash Cash	365175000	USD
CY2020Q4	us-gaap	Cash Cash	325554000	USD
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	520060000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	488011000	USD
CY2021Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	455604000	USD
CY2020Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	513954000	USD
CY2021Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	38694000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	39899000	USD
CY2021Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	416910000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	474055000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	39899000	USD
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	16068000	USD
CY2021Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2759000	USD
CY2020Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	6997000	USD
CY2021Q1	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	3306000	USD
CY2020Q1	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	2989000	USD
CY2021Q1	crto	Allowance For Doubtful Accounts Receivable Currency Translation Adjustment AllowanceForDoubtfulAccountsReceivableCurrencyTranslationAdjustment	658000	USD
CY2020Q1	crto	Allowance For Doubtful Accounts Receivable Currency Translation Adjustment AllowanceForDoubtfulAccountsReceivableCurrencyTranslationAdjustment	490000	USD
CY2021Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	38694000	USD
CY2020Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	23084000	USD
CY2021Q1	us-gaap	Proceeds Accounts Receivable Previously Written Off Recovery ProceedsAccountsReceivablePreviouslyWrittenOffRecovery	500000	USD
CY2020Q1	us-gaap	Proceeds Accounts Receivable Previously Written Off Recovery ProceedsAccountsReceivablePreviouslyWrittenOffRecovery	600000	USD
CY2021Q1	crto	Prepayments To Suppliers PrepaymentsToSuppliers	4362000	USD
CY2020Q4	crto	Prepayments To Suppliers PrepaymentsToSuppliers	5613000	USD
CY2021Q1	crto	Other Debtors OtherDebtors	3725000	USD
CY2020Q4	crto	Other Debtors OtherDebtors	5991000	USD
CY2021Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	14407000	USD
CY2020Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	9801000	USD
CY2021Q1	us-gaap	Other Assets Current OtherAssetsCurrent	22494000	USD
CY2020Q4	us-gaap	Other Assets Current OtherAssetsCurrent	21405000	USD
CY2021Q1	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	11575000	USD
CY2020Q4	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	12234000	USD
CY2021Q1	us-gaap	Notes Payable Current NotesPayableCurrent	15529000	USD
CY2020Q4	us-gaap	Notes Payable Current NotesPayableCurrent	14433000	USD
CY2021Q1	crto	Accounts Payable Capital Expenditures AccountsPayableCapitalExpenditures	2366000	USD
CY2020Q4	crto	Accounts Payable Capital Expenditures AccountsPayableCapitalExpenditures	4721000	USD
CY2021Q1	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	2235000	USD
CY2020Q4	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	1918000	USD
CY2021Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	988000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	84000	USD
CY2021Q1	crto	Accounts Payable Accrued Liabilities Employeerelated Payablesand Taxes Payable Current AccountsPayableAccruedLiabilitiesEmployeerelatedPayablesandTaxesPayableCurrent	32693000	USD
CY2020Q4	crto	Accounts Payable Accrued Liabilities Employeerelated Payablesand Taxes Payable Current AccountsPayableAccruedLiabilitiesEmployeerelatedPayablesandTaxesPayableCurrent	33390000	USD
CY2021Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	12941000	USD
CY2020Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	12850000	USD
CY2021Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	83000	USD
CY2020Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	342000	USD
CY2021Q1	us-gaap	Variable Lease Cost VariableLeaseCost	217000	USD
CY2020Q1	us-gaap	Variable Lease Cost VariableLeaseCost	525000	USD
CY2021Q1	us-gaap	Sublease Income SubleaseIncome	188000	USD
CY2020Q1	us-gaap	Sublease Income SubleaseIncome	202000	USD
CY2021Q1	us-gaap	Lease Cost LeaseCost	13053000	USD
CY2020Q1	us-gaap	Lease Cost LeaseCost	13515000	USD
CY2019Q4	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	8485000	USD
CY2020	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	2232000	USD
CY2020	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	95000	USD
CY2020	us-gaap	Defined Benefit Plan Actuarial Gain Loss DefinedBenefitPlanActuarialGainLoss	5214000	USD
CY2020	us-gaap	Defined Benefit Plan Foreign Currency Exchange Rate Changes Benefit Obligation DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation	-569000	USD
CY2020Q4	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	6167000	USD
CY2021Q1	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	337000	USD
CY2021Q1	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	13000	USD
CY2021Q1	us-gaap	Defined Benefit Plan Actuarial Gain Loss DefinedBenefitPlanActuarialGainLoss	629000	USD
CY2021Q1	us-gaap	Defined Benefit Plan Foreign Currency Exchange Rate Changes Benefit Obligation DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation	267000	USD
CY2021Q1	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	5621000	USD
CY2021Q1	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate	0.000125
CY2020	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate	0.0085
CY2021Q1	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation Increase DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease	0.0005
CY2020	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation Increase DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease	0.05
CY2021Q1	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	5553000	USD
CY2020	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	3429000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	541077000	USD
CY2020Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	503376000	USD
CY2020Q4	crto	Sharebased Compensation Arrangementby Sharebased Payment Award Equity Instruments Number SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsNumber	7400024	shares
CY2021Q1	crto	Sharebased Compensation Arrangementby Sharebased Payment Award Equity Instruments Grantsin Period SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsGrantsinPeriod	568148	shares
CY2020Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-300000	USD
CY2021Q1	crto	Sharebased Compensation Arrangementby Sharebased Payment Award Equity Instruments Exercised SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsExercised	101710	shares
CY2021Q1	crto	Sharebased Compensation Arrangementby Sharebased Payment Award Equity Instruments Vested SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsVested	181505	shares
CY2021Q1	crto	Sharebased Compensation Arrangementby Sharebased Payment Award Equity Instruments Forfeitedin Period SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsForfeitedinPeriod	225520	shares
CY2021Q1	crto	Sharebased Compensation Arrangementby Sharebased Payment Award Equity Instruments Expirationsin Period SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsExpirationsinPeriod	700	shares
CY2021Q1	crto	Sharebased Compensation Arrangementby Sharebased Payment Award Equity Instruments Number SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsNumber	7458737	shares
CY2021Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6760000	USD
CY2020Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8131000	USD
CY2021Q1	crto	Sharebased Compensation Expense Employeeand Non Employee SharebasedCompensationExpenseEmployeeandNonEmployee	7215000	USD
CY2020Q1	crto	Sharebased Compensation Expense Employeeand Non Employee SharebasedCompensationExpenseEmployeeandNonEmployee	8502000	USD
CY2020Q1	us-gaap	Debt Related Commitment Fees And Debt Issuance Costs DebtRelatedCommitmentFeesAndDebtIssuanceCosts	52000	USD
CY2021Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	128000	USD
CY2020Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	382000	USD
CY2021Q1	us-gaap	Interest Expense InterestExpense	540000	USD
CY2020Q1	us-gaap	Interest Expense InterestExpense	432000	USD
CY2021Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	417000	USD
CY2020Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	380000	USD
CY2021Q1	us-gaap	Debt Related Commitment Fees And Debt Issuance Costs DebtRelatedCommitmentFeesAndDebtIssuanceCosts	123000	USD
CY2021Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-798000	USD
CY2020Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-1628000	USD
CY2021Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	492000	USD
CY2020Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1344000	USD
CY2021Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-718000	USD
CY2020Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-334000	USD
CY2021Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-700000	USD
CY2021Q1	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	5053000	USD
CY2020Q1	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	9718000	USD
CY2021Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	4998000	USD
CY2020Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2678000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10051000	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7040000	USD
CY2021Q1	crto	Effective Income Tax Rate Reconciliation Estimated Tax Rate Percent EffectiveIncomeTaxRateReconciliationEstimatedTaxRatePercent	0.30
CY2020Q1	crto	Effective Income Tax Rate Reconciliation Estimated Tax Rate Percent EffectiveIncomeTaxRateReconciliationEstimatedTaxRatePercent	0.30
CY2021Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.30
CY2020Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.30
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	22406000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	15459000	USD
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	60741674	shares
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	61691001	shares
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.37
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.25
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	22406000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	15459000	USD
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	60741674	shares
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	61691001	shares
CY2021Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2972382	shares
CY2020Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	264309	shares
CY2021Q1	crto	Incremental Common Shares Attributableto Dilutive Effectof Sharebased Payment Arrangements Options And Bspce IncrementalCommonSharesAttributabletoDilutiveEffectofSharebasedPaymentArrangementsOptionsAndBSPCE	296071	shares
CY2020Q1	crto	Incremental Common Shares Attributableto Dilutive Effectof Sharebased Payment Arrangements Options And Bspce IncrementalCommonSharesAttributabletoDilutiveEffectofSharebasedPaymentArrangementsOptionsAndBSPCE	153786	shares
CY2021Q1	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	67282	shares
CY2020Q1	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	16486	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	64077409	shares
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	62125582	shares
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.35
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.25
CY2021Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	332300	shares
CY2020Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2241223	shares
CY2020Q4	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	2250000	USD
CY2021Q1	us-gaap	Loss Contingency Accrual Provision LossContingencyAccrualProvision	265000	USD
CY2021Q1	crto	Loss Contingency Accrual Provision Used LossContingencyAccrualProvisionUsed	247000	USD
CY2021Q1	crto	Loss Contingency Accrual Provision Released Not Used LossContingencyAccrualProvisionReleasedNotUsed	400000	USD
CY2021Q1	crto	Loss Contingency Accrual Foreign Currency Translation Gain Loss LossContingencyAccrualForeignCurrencyTranslationGainLoss	-95000	USD
CY2021Q1	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	1773000	USD
CY2021Q1	us-gaap	Loss Contingency Accrual Carrying Value Current LossContingencyAccrualCarryingValueCurrent	1773000	USD
CY2021Q1	crto	Numberof Geographical Marketsinwhich Entity Operates NumberofGeographicalMarketsinwhichEntityOperates	3	market
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	541077000	USD
CY2020Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	503376000	USD
CY2021Q1	us-gaap	Noncurrent Assets NoncurrentAssets	247476000	USD
CY2020Q4	us-gaap	Noncurrent Assets NoncurrentAssets	269249000	USD

Files In Submission

Name	View Source	Status
0001576427-21-000042-index-headers.html	Edgar Link	pending
0001576427-21-000042-index.html	Edgar Link	pending
0001576427-21-000042.txt	Edgar Link	pending
0001576427-21-000042-xbrl.zip	Edgar Link	pending
amendmenttoofferletter-s.htm	Edgar Link	pending
amendmenttoofferletter-s001.jpg	Edgar Link	pending
amendmenttoofferletter-s002.jpg	Edgar Link	pending
crto-20210331.htm	Edgar Link	pending
crto-20210331.xsd	Edgar Link	pending
crto-20210331_cal.xml	Edgar Link	unprocessable
crto-20210331_def.xml	Edgar Link	unprocessable
crto-20210331_htm.xml	Edgar Link	completed
crto-20210331_lab.xml	Edgar Link	unprocessable
crto-20210331_pre.xml	Edgar Link	unprocessable
exhibit311ceo10qq12021.htm	Edgar Link	pending
exhibit312cfo10qq22021.htm	Edgar Link	pending
exhibit321ceocfo10qq120201.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CRTO
Criteo S.A. Stock $crto

2021 Q1 Form 10-Q Financial Statement

#000157642721000042 Filed on May 05, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CRTO Criteo S.A. Stock $crto

2021 Q1 Form 10-Q Financial Statement

#000157642721000042 Filed on May 05, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CRTO
Criteo S.A. Stock $crto